These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4867776)

  • 1. Erythromycin, oleandomycin and triacetyloleandomycin.
    Ross S
    Pediatr Clin North Am; 1968 Feb; 15(1):119-29. PubMed ID: 4867776
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of triacetyloleandomycin on bacterial infections of the respiratory tract.
    WAREMBOURG H
    Antibiot Annu; 1959-1960; 7():816-8. PubMed ID: 13842895
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
    QUINN EL; COLVILLE JM; COX F
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():103-8. PubMed ID: 14435562
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin.
    HIRSCH HA; FINLAND M
    Am J Med Sci; 1959 Jun; 237(6):693-709. PubMed ID: 13661157
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with the antibiotic triacetyloleandomycin and the combination preparation tetracycline-oleandomycin in childhood].
    DIETEL V; MEISSNER F
    Dtsch Gesundheitsw; 1961 Dec; 16():2470-4. PubMed ID: 13886293
    [No Abstract]   [Full Text] [Related]  

  • 8. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
    Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
    J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleandomycin and triacetyloleandomycin.
    FOLTZ EL
    Pediatr Clin North Am; 1961 Nov; 8():1133-42. PubMed ID: 13893869
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacteriostatic activity exhibited by oleandomycin, triacetyl oleandomycin and spiramycin on mycobacteria].
    VIALLIER J; AUGAGNEUR J
    C R Seances Soc Biol Fil; 1962; 156():1435-7. PubMed ID: 13997027
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of otitis media with an oral antibiotic (triacetyloleandomycin).
    FOWLER PD
    Practitioner; 1961 Nov; 187():684-8. PubMed ID: 13894346
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of dysentery caused by antibiotic-resistant strains with triacetyloleandomycin (Taocin)].
    TOTANI T; YAMANAKA T; IIDA M; INAMURA Y
    Nihon Densenbyo Gakkai Zasshi; 1962 Jul; 36():139-51. PubMed ID: 13922102
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 14. [TRIACETYLOLEANDOMYCIN. TREATMENT OF CUTANEOUS INFECTIONS IN CHILDREN. (APROPOS OF 42 CASES)].
    CORCOS V
    Clinique (Paris); 1964 Jan; 59():61-6. PubMed ID: 14132244
    [No Abstract]   [Full Text] [Related]  

  • 15. TRIACETYLOLEANDOMYCIN.
    JERVEY L
    J S C Med Assoc (Columbia); 1964 May; 60():154-5. PubMed ID: 14145945
    [No Abstract]   [Full Text] [Related]  

  • 16. Triacetyloleandomycin, a two and one-half year study of in vitro susceptibility testing of antibiotic-resistant staphylococci.
    ENGLISH AR; FINK FC
    Antibiot Chemother (Northfield); 1961 Oct; 11():648-51. PubMed ID: 13890285
    [No Abstract]   [Full Text] [Related]  

  • 17. [MICROBIOLOGICAL STUDIES ON TRIACETYLOLEANDOMYCIN].
    VAKULENKO NA
    Antibiotiki; 1964 Nov; 9():1017-20. PubMed ID: 14320473
    [No Abstract]   [Full Text] [Related]  

  • 18. Triacetyloleandomycin: a report on its use in a general hospital.
    LEFEBVRE M; BELIVEAU D; DESILETS R; SIMARD J; CHARBONNEAU PE; LAFORTUNE L; ROY J
    Antibiot Annu; 1959-1960; 7():755-60. PubMed ID: 14415263
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood concentrations of oleandomycin after administration of triacetyloleandomycin].
    Caliò R; Pezzi R; Renzini G
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:2540-7. PubMed ID: 5294274
    [No Abstract]   [Full Text] [Related]  

  • 20. The microbiological characteristics of troleandomycin.
    Cocuzza G
    Quad Antibiot; 1975 Jun; ():18-34. PubMed ID: 1088736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.